Sanchia S. Goonewardene,
Raj Persad,
Hanif Motiwala,
David Albala
e.a.
Springer International Publishing
e druk, 2019
9783030286453
Management of Non-Muscle Invasive Bladder Cancer
Specificaties
Gebonden, blz.
|
Engels
Springer International Publishing |
e druk, 2019
ISBN13: 9783030286453
Rubricering
Verwachte levertijd ongeveer 9 werkdagen
Samenvatting
This book covers the latest advances in non-muscle invasive bladder cancer care. It provides a review of the available evidence base for the efficacy of a range of therapeutic techniques, diagnostic procedures and risk factors.
Management of Non-Muscle Invasive Bladder Cancer features detailed guidance in uniformly formatted chapters on how to properly apply a range of available therapeutic treatments relevant for patient care. It is a valuable resource for all trainee and practising medical professionals who treat these patients.
Specificaties
ISBN13:9783030286453
Taal:Engels
Bindwijze:gebonden
Uitgever:Springer International Publishing
Inhoudsopgave
<div>Bladder cancer survivorship.- Survivor burdens unmet needs.- CPEX testing in bladder cancer.- Management of low, intermediate and high risk bladder cancer.- Neoadjuvant chemotherapy in muscle invasive bladder cancer.- Multimodal therapy for muscle invasive bladder cancer .- None Muscle invasive bladder cancer- chemotherapy or resection.- Muscle invasive bladder cancer- open, laparoscopic or roboticG3 NMIBC- BCG versus cystectomy.- Role of immunotherapy in bladder cancer .- Robotic Surgery and bladder cancer.- Quality of life post Cystectomy.- The Neobladder and Quality of life.- Ileal conduit versus neobladder, which is better?.- Quality of life post NMIBC or BCG.- Rarc technical tips and tricks.- Robotic Surgery and resection.- Robotic radical cystectomy and PLND.- Robotic cystectomy and sentinal node mapping.- Robotic cystectomy and neobladder formation.- Robotic cystectomy and enhanced recovery.- Robotic radical cystectomy, pain and enhanced recovery.- Enhanced recovery and hypoalbumineamia.- The Robotic approach to redo surgery.- Robotic cystectomy and ureteric strictures.- BCG and cystectomy.- BCG and secondary malignancy. </div><div><br></div>